Evidence supporting the use of: N-Acetyl Cysteine
For the health condition: Anxiety Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

N-Acetyl Cysteine (NAC) has some scientific evidence supporting its use in anxiety disorders, though this evidence is still preliminary and not conclusive. NAC is a precursor to the antioxidant glutathione and has been studied for its effects on glutamate modulation and oxidative stress, both of which are implicated in the pathophysiology of anxiety and related disorders.

Several small clinical trials and open-label studies have investigated NAC in psychiatric conditions such as obsessive-compulsive disorder (OCD), trichotillomania, and generalized anxiety disorder (GAD). Some of these studies suggest that NAC may reduce anxiety symptoms, possibly by modulating glutamatergic neurotransmission and reducing oxidative stress. For example, a few randomized controlled trials (RCTs) have shown modest benefit as an adjunctive treatment in OCD and related disorders, while others have not found significant effects in primary anxiety disorders.

Systematic reviews and meta-analyses generally conclude that NAC shows promise, but the quality and quantity of evidence are limited. The studies tend to be small, heterogeneous, and sometimes methodologically weak. As of 2024, major psychiatric guidelines do not recommend NAC as a first-line treatment for anxiety disorders, but ongoing research may clarify its potential role.

In summary, there is preliminary scientific evidence for the use of NAC in anxiety disorders, but it is not strong or definitive. More robust, large-scale clinical trials are needed to establish its efficacy and safety for this indication.

More about N-Acetyl Cysteine
More about Anxiety Disorders

Products containing N-Acetyl Cysteine

We currently have no products on Vitabase that contain this ingredient.